COLUMBIA, Md., Jan. 21 /PRNewswire-FirstCall/ -- Martek Biosciences (Nasdaq: MATK) announced today that life'sDHA(TM), its patented, vegetarian form of DHA omega-3 for brain, eye and heart health, is now available to Australian consumers in Pocket Rocket Juice sold at Boost Juice Bars nationwide. Boost Juice is the largest juice and smoothie chain in the Southern Hemisphere.
Featuring 700 mg of life'sDHA per serving, Pocket Rocket Juice provides more than 100 percent of Australia's suggested dietary intake of omega-3s as established by the Australian government. It is estimated that Australians eating an average diet consume only 189 mg of omega-3s per day, far less than Australia's suggested dietary intake of between 430 and 610 mg.
"The Pocket Rocket Juice from Boost Juice illustrates the continued growth of products with life'sDHA in the Australian market," said Joe Buron, vice president of marketing and sales for Martek. "We're pleased to be working with one of Australia's biggest franchise brands to make life'sDHA more available to consumers."
DHA (docosahexaenoic acid) omega-3 is a long-chain omega-3 fatty acid that serves as a primary building block for the brain and the eyes and supports brain, eye and cardiovascular health throughout life. There is a large and growing body of scientific evidence demonstrating that people of all ages, from infants to aging adults, benefit from an adequate supply of DHA omega-3 in their diets. Scientific reviews have noted the importance of DHA omega-3 in proper brain and eye development and function, and there are large clinical studies underway to evaluate its role in decreasing the prevalence of certain neurological disorders.
In the Nutrient Reference Values for Australia and New Zealand including Recommended Dietary Intakes, the Australian government suggests intakes of 610 mg of omega-3 fatty acids (DHA/ DPA/EPA) per day for adult males and 430 mg per day for adult females.
Fish are often thought to be the only source of DHA omega-3. However, life'sDHA offers a trusted, vegetarian form of DHA that contains no oceanic pollutants and toxins. Fish are good sources of DHA because of the DHA-rich microalgae in their food chain; life'sDHA is derived from microalgae and produced in an FDA-inspected facility from start to finish using a sustainable source that does not deplete ocean resources. life'sDHA is found in numerous foods, beverage and supplements for people of all ages. It is also the only source of DHA used in U.S. infant formula and is available in more than 90 percent of the formulas on the U.S. market.
In Australia, Martek is represented by distributor VILCO PTY LTD, Australia, to help expand the market for life'sDHA in food and beverages in Australia.
Boost Juice Bars
Boost was born in 2000 when founder Janine Allis visited the U.S. to research the growing phenomenon of the juice and smoothie market and realized there was a huge gap for a healthy fast food alternative in Australia. Once returning to Australia, she developed the concept and opened Boost's first store in King William St, Adelaide. Now Boost Juice Bars has 200 stores in eight countries as well as products sold in grocery markets. For more information on Boost Juice Bars, visit http://www.boostjuicebars.com.
Martek Biosciences Corporation
Martek Biosciences Corporation (Nasdaq: MATK) is a leader in the innovation and development of DHA omega-3 products that promote health and wellness through every stage of life. The company produces life'sDHA(TM), a sustainable and vegetarian source of the omega-3 fatty acid DHA (docosahexaenoic acid), for use in foods, beverages, infant formula, and supplements. The company also produces life'sARA(TM) (arachidonic acid), an omega-6 fatty acid, from a sustainable, vegetarian source, for use in infant formula. For more information on Martek Biosciences Corporation, visit http://www.martek.com. For a complete listing of life'sDHA products, visit http://www.lifesdha.com.
Sections of this release contain forward-looking statements. These
statements are based upon numerous assumptions which Martek cannot control
and involve risks and uncertainties that could cause actual results to
differ. These statements should be understood in light of the risk factors
set forth in the company's filings with the Securities and Exchange
Commission, including, but not limited to, the company's Form 10-K for the
fiscal year ended October 31, 2007 and other filed reports on Form 10-K,
Form 10-K/A, Form 10-Q and Form 8-K.
Consumer and Trade Media
|SOURCE Martek Biosciences|
Copyright©2008 PR Newswire.
All rights reserved